Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00059887.xml
CC BY 4.0 · Brazilian Journal of Oncology 2025; 21
DOI: 10.1055/s-0045-1807914
DOI: 10.1055/s-0045-1807914
ONCOGENETICS
1996
POSTER PRESENTATION
Safety analysis according to UGT1A1 status in patients treated with sacituzumab govitecan: a systematic review and meta-analysis
Publication History
Article published online:
06 May 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Bibliographical Record
Isabella Michelon, Jonathan Priantti, Caio Ernesto do Rego Castro, Thiago Madeira, Gilca Costa Nachtigal. Safety analysis according to UGT1A1 status in patients treated with sacituzumab govitecan: a systematic review and meta-analysis. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807914
Isabella Michelon, Jonathan Priantti, Caio Ernesto do Rego Castro, Thiago Madeira, Gilca Costa Nachtigal. Safety analysis according to UGT1A1 status in patients treated with sacituzumab govitecan: a systematic review and meta-analysis. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807914